How big is the Anti-Viral Therapeutics Market?

The Anti-Viral Therapeutics Market size is expected to reach USD 55.57 billion in 2024 and grow at a CAGR of 2.06% to reach USD 61.54 billion by 2029. Read More

What is the current Anti-Viral Therapeutics Market size?

In 2024, the Anti-Viral Therapeutics Market size is expected to reach USD 55.57 billion. Read More

Who are the key players in Anti-Viral Therapeutics Market?

AbbVie Inc., Bristol-Myers Squibb Company, Gilead Sciences Inc., F. Hoffman-La Roche Ltd and Cipla Inc. are the major companies operating in the Anti-Viral Therapeutics Market. Read More

Which is the fastest growing region in Anti-Viral Therapeutics Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Anti-Viral Therapeutics Market?

In 2024, the North America accounts for the largest market share in Anti-Viral Therapeutics Market. Read More

What years does this Anti-Viral Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Anti-Viral Therapeutics Market size was estimated at USD 54.43 billion. The report covers the Anti-Viral Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Anti-Viral Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the growth opportunities in the Antiviral Drugs Market?

The growth opportunities in the Antiviral Drugs Market are a) Growing emphasis on global health security can lead to increased investment in antiviral drug development and stockpiling b) Development of drugs effective against a wider range of viruses can be beneficial for public health preparedness Read More

What are the growth opportunities in the Antiviral Drugs Market?

The growth opportunities in the Antiviral Drugs Market are a) Growing emphasis on global health security can lead to increased investment in antiviral drug development and stockpiling b) Development of drugs effective against a wider range of viruses can be beneficial for public health preparedness Read More

Anti-Viral Therapeutics Market Size & Share Analysis - Industry Research Report

Anti-Viral Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Anti-Viral Therapeutics Market is Segmented by Drug Type (Herpes Anti-Viral Drugs, Hepatitis Anti-Viral Drugs, HIV Anti-Viral Drugs, Influenza Anti-Viral Drugs, and Other Anti-Viral Drugs), Distribution Channel (Hospital Pharmacy, Independent Pharmacy, and Drug Store, Online Pharmacy), and Geography (North America (United States, Canada, and Mexico), Europe ) Germany, United Kingdom, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, and the Rest of Middle East and Africa), and South America Brazil, Argentina, and Rest of South America)). The Report Offers Value (in USD Million) for the Above Segments.

Anti-Viral Therapeutics Industry Overview

The anti-viral therapeutics market is moderately competitive. Some of the major players in the anti-viral therapeutics market are AbbVie Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Johnson & Johnson, Merck and Co. Inc. The anti-viral therapeutics market is a fast-growing market. The major players in the market are adopting organic and inorganic strategies to survive and expand. Moreover, the key players are focusing on increasing US Food and Drug Administration (FDA) approvals and product launches to leverage current and future market opportunities.